Portfolio Prioritization Frameworks
Choose what to fund — and what to kill.
Defensible portfolio prioritization frameworks for pharma — combining NPV, strategic fit, time-to-impact and capacity to drive fund-vs-kill decisions.
"Which portfolio assets should we fund harder, hold, or kill?"
Portfolio prioritization is about killing as much as funding. Defensible frameworks make kill decisions visible and tied to thresholds, not politics.
Portfolio prioritization is the discipline of deciding what to kill. The teams that execute it defensibly — with thresholds, capacity and audit — are the teams that maintain healthy pipelines.
What we’re seeing in the data.
Killing is the hardest call
Most portfolios over-fund mid-tier assets.
Capacity reveals real bandwidth
FTE and capital constraints surface real choices.
Threshold-based reduces politics
Pre-defined kill thresholds remove personalization.
Time-to-impact compounds value
Faster wins protect medium-term portfolio.
How to think about it.
-
01
Score every asset
NPV / fit / time / capability.
-
02
Apply capacity constraint
FTE, capital, infrastructure.
-
03
Define kill thresholds
Pre-set, public.
-
04
Surface fund / hold / kill
Three buckets.
-
05
Quarterly portfolio review
With audit of prior decisions.
What separates a good answer from a defensible one.
Watch for invested-time defense of weak assets.
Some "kill" assets carry option upside.
Some assets only valuable bundled.
Kill decisions affect investor messaging.
Where the signal comes from.
Common questions.
How often should portfolio be re-prioritized?
Quarterly. More frequent destabilizes execution; less frequent allows drift.
How public should kill decisions be?
Internally fully transparent; externally calibrated to investor narrative.
Want this answered on your data?
We build decision systems on top of analyses like this — so the next question takes minutes, not weeks.
Talk to a strategist